Immediate Impact
3 by Nobel laureates 2 from Science/Nature 68 standout
Citing Papers
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy
2022 Standout
Targeting the HIF2–VEGF axis in renal cell carcinoma
2020 StandoutNobel
Works of Herb Kotz being referenced
Correlative studies of a phase I trial of combination anti-vascular endothelial growth factor (VEGF) therapy with sorafenib and bevacizumab
2008
Increased efficacy and toxicity with combination anti-VEGF therapy using sorafenib and bevacizumab
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Herb Kotz | 320 | 150 | 131 | 23 | 486 | |
| Antonella Perotti | 309 | 227 | 140 | 24 | 574 | |
| Jean Pierre Lotz | 362 | 114 | 125 | 21 | 552 | |
| Marius Giurescu | 287 | 174 | 69 | 26 | 487 | |
| Awatif Al‐Nafussi | 109 | 148 | 106 | 21 | 478 | |
| P Bastit | 284 | 132 | 93 | 29 | 533 | |
| O. Rixe | 348 | 89 | 126 | 16 | 471 | |
| Elisabet Hjerpe | 167 | 199 | 36 | 19 | 500 | |
| Marta Lomnytska | 116 | 349 | 65 | 20 | 559 | |
| Vincenzo Rosario Iaffaioli | 310 | 133 | 76 | 25 | 511 | |
| Véronique Haddad | 318 | 272 | 101 | 23 | 530 |
All Works
Loading papers...